Roth CH Acquisition IV Co. (ROCG) Ends Exclusivity with LOI Target
by Nicholas Alan Clayton on 2022-09-19 at 9:20am

Roth CH IV (NASDAQ:ROCG) announced in an 8-K this morning that its letter of intent (LOI) to combine with a target company is no longer exclusive.

The SPAC noted that negotiations for the deal remain ongoing, but both parties may seek out other transactions. Roth CH IV’s initial announcement on June 15 revealed no detail about the company in question, so this does seem a situation of “so long, we hardly knew ya.'” But, of course, this deal could still be negotiated into a definitive agreement.

Announcing LOIs has become somewhat more common in recent months, perhaps because some SPACs are looking at shorter deadlines and want to keep investors engaged ahead of any upcoming extension votes. Six SPACs announced LOIs with targets since Roth CH IV did so in June, but only one of these has announced a definitive agreement since – East Resources (NASDAQ:ERES) and its combination with Abacus Life.

Two of these SPACs – Alpha Star (NASDAQ:ALSA) and Chavant (NASDAQ:CLAY) – have extended their transaction deadlines in the interim.

Roth CH Acquisition IV Co. (ROCG) Ends Exclusivity with LOI Target
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 3:49pm

D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...

by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

by Henrique Santa Rosa, CFA on 2025-07-01 at 11:09am

In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...

by Kristi Marvin on 2025-07-01 at 8:42am

An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...

by Nicholas Alan Clayton on 2025-07-01 at 8:25am

At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved